newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Proposed Public Offering of Common Stock

ImmunoGen Inc. (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that it intends to offer and sell, subject to market and other conditions,